High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world. [electronic resource]
Producer: 20201221Description: 876-888 p. digitalISSN:- 1600-0641
- Anilides -- therapeutic use
- Antiviral Agents -- pharmacology
- Benzimidazoles -- therapeutic use
- Carbamates -- therapeutic use
- Cyclopropanes -- therapeutic use
- Drug Resistance, Viral -- genetics
- Drug Therapy, Combination
- Female
- Fluorenes -- therapeutic use
- Genotype
- Hepacivirus -- genetics
- Hepatitis C -- drug therapy
- Humans
- Imidazoles -- therapeutic use
- Lactams, Macrocyclic -- therapeutic use
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Prospective Studies
- Pyrrolidines
- Retreatment
- Ribavirin -- therapeutic use
- Ritonavir -- therapeutic use
- Sofosbuvir -- therapeutic use
- Spain -- epidemiology
- Sulfonamides -- therapeutic use
- Sustained Virologic Response
- Valine -- analogs & derivatives
- Viral Nonstructural Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.